You are adding an alert for:
Rapid structural and functional improvements following 0.19 mg fluocinolone acetonide (FAc) implant in diabetic macular edema patients with poor visual acuity: 6-month audit results from The United Arab Emirates.
You will receive an email whenever this article is corrected, updated, or cited in the literature. You can manage this and all other alerts in My Account
The alert will be sent to: